Analyst Ratings for Chinook Therapeutics (KDNY)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 1.7 / 10
Percentile Rank: 12%
Rating Score: 1.7 / 10
Percentile Rank: 12%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2023 | Wedbush | Laura Chico | Downgrade | Neutral (Outperform) |
42.00 (N/A) |
40.35 (40.39) |
0.1% | Details |
| 8/1/2023 | Wells Fargo | Mohit Bansal | Downgrade | Equal Weight (Overweight) |
40.00 (30.00) |
39.08 (40.39) |
3.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
